FDA approved
Onco
Daily
Twitter
Facebook
Youtube
RSS Feed
Linkedin
Facebook
RSS
Twitter
Youtube
Linkedin
May, 2024
May 2024
M
T
W
T
F
S
S
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
« Apr
FDA approved
Apr 22, 2024, 05:14 |
Insight
Chul Kim: In-depth review of BRAF mutant NSCLC by Dr. Marcelo Negrao at Texas Lung 24 Conference
Chul Kim, Thoracic Medical Oncologist at Georgetown University, shared a post on X: "In-depth review…
Apr 19, 2024, 15:52 |
Drugs
FDA approves alectinib as adjuvant treatment for ALK-positive non-small cell lung cancer based on ALINA trial
FDA, the Food and Drug Administration approved alectinib (Alecensa, Genentech, Inc.) for adjuvant treatment following…
Apr 8, 2024, 03:54 |
Drugs
Paolo Tarantino: Trastuzumab deruxtecan is now FDA approved for ANY treatment-refractory HER2+ solid tumor
Paolo Tarantino, Advanced Research Fellow in the Breast Oncology Program at Dana-Farber Cancer Institute, shared…
Apr 8, 2024, 03:45 |
Drugs
Vivek Subbiah: First ADC tissue agnostic drug approved!
Quoting Vivek Subbiah's post on LinkedIn: "Just in time for American Association for Cancer Research…
Mar 19, 2024, 16:03 |
Drugs
FDA granted accelerated approval to ponatinib with chemotherapy for adult patients with newly diagnosed Philadelphia chromosome-positive acute lymphoblastic leukemia.
FDA Oncology Center of Excellence shared on X (Twitter): "On March 19, 2024, the Food…
Feb 19, 2024, 17:05 |
Drugs
Patrick Hwu: The FDA approved a groundbreaking treatment called TIL Therapy for advanced melanoma
Patrick Hwu, President and CEO at Moffitt Cancer Center, shared on LinkedIn: "Today, the FDA…
Dec 24, 2023, 18:54 |
Drugs
Laurie Glimcher: Belzutifan is approved by the FDA
Laurie Glimcher, President and CEO of Dana-Farber Cancer Institute, shared on X/Twitter: "Exciting news that…
Dec 18, 2023, 03:52 |
Drugs
FDA approved enfortumab vedotin-ejfv with pembrolizumab for patients with locally advanced or metastatic urothelial cancer
FDA Oncology shared on X: "On December 15, 2023, the Food and Drug Administration (FDA)…
All:
8
Posts:
1 - 10
10 Most Promising Cancer Drugs Not Yet Approved: Solid Tumors
Elie G. Dib: Excited to share the results of the TAPUR study
OncoInfluencers: Dialogue with Fadlo R. Khuri, hosted by Gevorg Tamamyan
Cedars-Sinai is co-chairing a special AACR conference on transforming the field of Bladder Cancer on May 17-20
Barbara Jereczek-Fossa has been elected as the ESTRO President-elect!
Facebook
RSS Feed
Twitter
Linkedin
Youtube